Nrx Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 0.0606
NRXPW Stock | USD 0.07 0.03 30.00% |
NRx |
NRx Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NRx Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NRx Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.NRx Pharmaceuticals is way too risky over 90 days horizon | |
NRx Pharmaceuticals has some characteristics of a very speculative penny stock | |
NRx Pharmaceuticals appears to be risky and price may revert if volatility continues | |
NRx Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
Net Loss for the year was (30.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
NRx Pharmaceuticals has accumulated about 24.55 M in cash with (21.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
NRx Pharmaceuticals has a poor financial position based on the latest SEC disclosures |
NRx Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NRx Stock often depends not only on the future outlook of the current and potential NRx Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NRx Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 7.6 M | |
Cash And Short Term Investments | 4.6 M |
NRx Pharmaceuticals Technical Analysis
NRx Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. NRx Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NRx Pharmaceuticals. In general, you should focus on analyzing NRx Stock price patterns and their correlations with different microeconomic environments and drivers.
NRx Pharmaceuticals Predictive Forecast Models
NRx Pharmaceuticals' time-series forecasting models is one of many NRx Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary NRx Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about NRx Pharmaceuticals
Checking the ongoing alerts about NRx Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for NRx Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
NRx Pharmaceuticals is way too risky over 90 days horizon | |
NRx Pharmaceuticals has some characteristics of a very speculative penny stock | |
NRx Pharmaceuticals appears to be risky and price may revert if volatility continues | |
NRx Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
Net Loss for the year was (30.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
NRx Pharmaceuticals has accumulated about 24.55 M in cash with (21.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
NRx Pharmaceuticals has a poor financial position based on the latest SEC disclosures |
Additional Tools for NRx Stock Analysis
When running NRx Pharmaceuticals' price analysis, check to measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.